World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
39
Citations
4538
World Ranking
8406
National Ranking
295

Overview

Takeharu Kakiuchi is a researcher affiliated with Hamamatsu Photonics in Japan. Their work prominently centers on the fields of medicine and neuroscience, with a notable focus on subfields such as psychiatry and mental health, oncology, pediatrics, perinatology and child health, genetics, and physiology.

Their primary research topics cover diverse areas including:

  • Drug Transport and Resistance Mechanisms
  • Pharmacological Effects and Toxicity Studies
  • Alzheimer's disease research and treatments
  • Epilepsy research and treatment
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Dementia and Cognitive Impairment Research
  • Glioma Diagnosis and Treatment

Takeharu Kakiuchi has contributed to several research papers that reflect their interest in pharmacokinetic modeling, neurodegenerative diseases, and molecular imaging. Recent publications include:

  • Pharmacokinetic Modeling of 18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PET, 2020, Molecular Pharmaceutics
  • Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates, 2020, Molecular Pharmaceutics
  • Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β-peptide, 2023, EMBO Molecular Medicine
  • Early distribution of 18F-labeled AAV9 vectors in the cerebrospinal fluid after intracerebroventricular or intracisternal magna infusion in non-human primates, 2022, The Journal of Gene Medicine

Frequent co-authors include:

  • Norihiro Harada
  • Hideo Tsukada
  • Hiroyuki Ohba
  • Shingo Nishiyama
  • Tetsuro Tago

Takeharu Kakiuchi's publications appear regularly in venues such as:

  • Molecular Pharmaceutics
  • European Journal of Nuclear Medicine and Molecular Imaging
  • The Journal of Gene Medicine
  • EMBO Molecular Medicine
  • EJNMMI Research

Best Publications

  • Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis

    Hideo Tsukada;Norihiro Harada;Shingo Nishiyama;Hiroyuki Ohba

  • Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain

    Hideo Tsukada;Shingo Nishiyama;Takeharu Kakiuchi;Hiroyuki Ohba

  • Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.

    Kenji Hashimoto;Takeharu Kakiuchi;Hiroyuki Ohba;Shingo Nishiyama

  • Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

    Hideo Tsukada;Shingo Nishiyama;Takeharu Kakiuchi;Hiroyuki Ohba

  • Comparative effects of methamphetamine and nicotine on the striatal [11C]raclopride binding in unanesthetized monkeys

    Hideo Tsukada;Katsumasa Miyasato;Takeharu Kakiuchi;Shingo Nishiyama

  • Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.

    Masahiro Sugiyama;Harumi Sakahara;Kengo Sato;Norihiro Harada

  • Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys.

    Hideo Tsukada;Takeharu Kakiuchi;Dai Fukumoto;Shingo Nishiyama

  • Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.

    Hideo Tsukada;Jason Kreuter;Christopher E. Maggos;Ellen M. Unterwald;Ellen M. Unterwald

  • Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.

    Hideo Tsukada;Shingo Nishiyama;Dai Fukumoto;Kengo Sato

  • Cholinergic Neuronal Modulation Alters Dopamine D2Receptor Availability In Vivo by Regulating Receptor Affinity Induced by Facilitated Synaptic Dopamine Turnover: Positron Emission Tomography Studies with Microdialysis in the Conscious Monkey Brain

    Hideo Tsukada;Norihiro Harada;Shingo Nishiyama;Hiroyuki Ohba

  • Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys.

    Akihiro Noda;Hiroyuki Ohba;Takeharu Kakiuchi;Masami Futatsubashi

  • Decline of striatal dopamine release in parkin‐deficient mice shown by ex vivo autoradiography

    Shigeto Sato;Shigeto Sato;Tomoki Chiba;Shingo Nishiyama;Takeharu Kakiuchi

  • Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.

    Hideo Tsukada;Shingo Nishiyama;Takeharu Kakiuchi;Hiroyuki Ohba

  • Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys

    Shigeyuki Yamamoto;Hiroyuki Ohba;Shingo Nishiyama;Norihiro Harada

  • Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis.

    Hideo Tsukada;Shingo Nishiyama;Dai Fukumoto;Hiroyuki Ohba

  • Evaluation of d-Isomers of O-11C-Methyl Tyrosine and O-18F-Fluoromethyl Tyrosine as Tumor-Imaging Agents in Tumor-Bearing Mice: Comparison with l- and d-11C-Methionine

    Hideo Tsukada;Kengo Sato;Dai Fukumoto;Shingo Nishiyama

  • Age-related impairment of coupling mechanism between neuronal activation and functional cerebral blood flow response was restored by cholinesterase inhibition: PET study with microdialysis in the awake monkey brain.

    Hideo Tsukada;Kengo Sato;Takeharu Kakiuchi;Shingo Nishiyama

  • An increase of sigma1 receptors in the aged monkey brain

    Kazunori Kawamura;Yuichi Kimura;Hideo Tsukada;Tadayuki Kobayashi

  • Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine.

    Kenji Hashimoto;Hideo Tsukada;Shingo Nishiyama;Dai Fukumoto

  • Sustained Withdrawal Allows Normalization of In Vivo [11C]N-Methylspiperone Dopamine D2 Receptor Binding after Chronic Binge Cocaine: A Positron Emission Tomography Study in Rats

    Christopher E Maggos;Hideo Tsukada;Takeharu Kakiuchi;Shingo Nishiyama

Frequent Co-Authors

Hideo Tsukada
Hideo Tsukada Hamamatsu Photonics (Japan)
Shingo Nishiyama
Shingo Nishiyama Hamamatsu Photonics (Japan)
Kazuo Sasaki
Kazuo Sasaki National Institutes of Natural Sciences
Yasuomi Ouchi
Yasuomi Ouchi Hamamatsu University
Edward F. Domino
Edward F. Domino University of Michigan–Ann Arbor
Kohji Sato
Kohji Sato Hamamatsu University
Yasuyoshi Watanabe
Yasuyoshi Watanabe Osaka Metropolitan University
Hirotaka Onoe
Hirotaka Onoe Kyoto University
Shin-ichi Muramatsu
Shin-ichi Muramatsu Jichi Medical University
Kengo Ito
Kengo Ito Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Takeharu Kakiuchi

Trending Scientists